Product Information
FT NALOXONE HCL 4 MG NASAL SPR is a generic product labeled by Strategic Sourcing Services LLC, priced at $17.1773 per EA under NDC 70677128301. Its NADAC has been published 62 times since Jul 30, 2025.
FDA first approved this application on Jun 21, 2022.
Strength
4 mg/.1mL
Manufacturer
Strategic Sourcing Services LLCNDC
70677128301
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211951FDA Approved
6/21/2022
On Market Since
4/1/2025
Pharmacological Classes
Price Statistics
The NADAC for FT NALOXONE HCL 4 MG NASAL SPR has been published 62 times since Jul 30, 2025, and over the history we have for it it has declined 32.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.1773 per EA |
|---|---|
| All-time high | $25.5156 (Aug 13, 2025) |
| All-time low | $15.2248 (May 20, 2026) |
| 52-week high | $22.8128 |
| 52-week low | $15.2248 |
| Median price | $15.5794 |
| Average price | $17.6928 |
| Largest weekly change | -32.4% (Nov 19, 2025) |
| Weeks tracked | 62 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naloxone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT NALOXONE HCL 4 MG NASAL SPR?
The current National Average Drug Acquisition Cost (NADAC) for FT NALOXONE HCL 4 MG NASAL SPR, manufactured by Strategic Sourcing Services LLC, is $17.1773 per EA (NDC 70677128301), effective Sep 30, 2026.
How has the price of FT NALOXONE HCL 4 MG NASAL SPR changed over time?
Over the history we have for it, the NADAC for FT NALOXONE HCL 4 MG NASAL SPR has declined 32.7%. It has been tracked across 62 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for FT NALOXONE HCL 4 MG NASAL SPR?
Since Jul 30, 2025, the NADAC for FT NALOXONE HCL 4 MG NASAL SPR has ranged from a low of $15.2248 (May 20, 2026) to a high of $25.5156 (Aug 13, 2025), with a median of $15.5794 per EA.
Are there cheaper alternatives to FT NALOXONE HCL 4 MG NASAL SPR?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT NALOXONE HCL 4 MG NASAL SPR in a comparable dosage form, but none are currently priced below it.
Who manufactures FT NALOXONE HCL 4 MG NASAL SPR?
FT NALOXONE HCL 4 MG NASAL SPR (NDC 70677128301) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.